Search company, investor...

Predict your next investment

Jump Capital company logo
Venture Capital
jumpcap.com

Investments

225

Portfolio Exits

29

Funds

5

Service Providers

1

About Jump Capital

Jump Capital is a venture capital firm. It specializes in scalable software opportunities in financial technology, cryptocurrency, information technology (IT), and data infrastructure. The firm was founded in 2012 and is based in Chicago, Illinois.

Headquarters Location

600 W Chicago Avenue Suite 825

Chicago, Illinois, 60654,

United States

312-205-8760

Are you an investor?
Submit your portfolio details now to be considered in our investor rankings.

Research containing Jump Capital

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Jump Capital in 1 CB Insights research brief, most recently on Apr 21, 2023.

Latest Jump Capital News

08:00 ET Frazier Life Sciences Welcomes Lauren Mifflin as Vice President of Company Creation

Nov 30, 2023

News provided by Share this article Share toX MENLO PARK, Calif., Nov. 30, 2023 /PRNewswire/ -- Frazier Life Sciences (FLS), a longstanding venture capital firm investing in innovative biopharmaceuticals, is pleased to announce the appointment of Lauren Mifflin, Ph.D., as vice president of company creation. Lauren brings over 12 years of experience in building and growing life sciences and healthcare companies, making her a valuable addition to the FLS team. Based in Boston, Lauren will be implementing FLS' methodical approach to company creation, characterized by an asset-centric portfolio strategy derived from over two decades worth of institutional knowledge. "We are excited to welcome Lauren to Frazier Life Sciences," commented Dan Estes, Ph.D., general partner at FLS. "Company creation is a core component of our venture investment strategy, and Lauren will further enhance our capabilities to potentially create world-class biopharmaceutical companies, particularly in the area of biologics. " Prior to joining FLS, Lauren was a venture partner at 82VS, the venture studio of Alloy Therapeutics. She helped to build biologics companies leveraging Alloy's discovery capabilities, including co-founding a company creating T-cell receptor mimic (TCRm) therapeutics for solid tumor indications. Before her time at 82VS, Lauren was a fellow and 4:59 operating associate at 5AM Ventures, focusing on evaluating investment opportunities and building new life sciences companies. In this capacity, Lauren worked with the founding team of Entrada Therapeutics and was a member of the founding team of Nido Biosciences, spanning strategy, operations and scientific discovery roles. Early in her career, Lauren was a health tech investor at Jump Capital and management consultant at Monitor Group/Monitor Deloitte. With a proven track record in venture creation and a passion for integrating business and science, Lauren is well-positioned to contribute significantly to FLS' ongoing success. "Amidst challenging market cycles, I believe Frazier Life Sciences has solidified its position as a key player investing strategically across preclinical science and company creation," said Lauren Mifflin, Ph.D., vice president at FLS. "It is a true privilege to join a team celebrated for its deep commitment to scientific rigor and I look forward to leveraging my background to help advance novel life science companies focused on patients' unmet needs." "Lauren's track record in company formation, particularly within the dynamic Boston biotech ecosystem, positions her as an important asset for us to continue to build out the Frazier Life Sciences portfolio on the East Coast," added Joe Cabral, vice president at FLS. "We look forward to collaborating with Lauren to identify unique opportunities that are consistent with our investment philosophy and offer the potential for transformative patient impact." About Frazier Life Sciences: Frazier Life Sciences invests globally in private and publicly-traded companies that discover, develop and commercialize innovative biopharmaceuticals. Frazier Life Sciences' funds comprise over $3.3 billion in capital raised, including venture funds focusing on company creation and private companies, and public funds focused on small and mid-cap public companies. Since 2005, over 60 Frazier Life Sciences portfolio companies, many of which were created or seeded by Frazier, have completed IPOs or M&As. The Frazier Life Sciences team consists of over 40 professionals with deep experience in biopharmaceuticals, primarily located in Menlo Park, Calif. (headquarters), San Diego, Seattle, Boston, New York and London. Operating professionals (including company creation professionals) were not compensated for the statements regarding their business relationship with Frazier Life Sciences. Such persons will receive ordinary course compensation as part of their company creation efforts and hold a material equity position in the search company associated with them. Such search company is controlled and funded by a venture fund associated with Frazier Life Sciences. Accordingly, there are certain conflicts of interest relating to such operating professionals because they are employed by a Frazier Life Sciences subsidiary and receive compensation and benefits in connection with such employment that are ultimately paid by the search company. For more information about Frazier Life Sciences, please visit frazierls.com . SOURCE Frazier Life Sciences

Jump Capital Investments

225 Investments

Jump Capital has made 225 investments. Their latest investment was in Ternary as part of their Series A on October 10, 2023.

CBI Logo

Jump Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

10/23/2023

Series A

Ternary

$12M

Yes

5

10/17/2023

Seed VC - II

Squads Labs

$5.7M

No

1

8/24/2023

Seed VC

Cypago

$13M

Yes

2

8/24/2023

Series C

Subscribe to see more

Subscribe to see more

10

8/10/2023

Series B

Subscribe to see more

$99M

Subscribe to see more

10

Date

10/23/2023

10/17/2023

8/24/2023

8/24/2023

8/10/2023

Round

Series A

Seed VC - II

Seed VC

Series C

Series B

Company

Ternary

Squads Labs

Cypago

Subscribe to see more

Subscribe to see more

Amount

$12M

$5.7M

$13M

$99M

New?

Yes

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

5

1

2

10

10

Jump Capital Portfolio Exits

29 Portfolio Exits

Jump Capital has 29 portfolio exits. Their latest portfolio exit was Enso Security on June 07, 2023.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

6/7/2023

Acquired

$99M

6

2/22/2023

Acquired

$99M

1

1/26/2023

Acquired

$99M

13

12/3/2022

Acq - Fin

Subscribe to see more

$99M

Subscribe to see more

10

6/22/2022

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/7/2023

2/22/2023

1/26/2023

12/3/2022

6/22/2022

Exit

Acquired

Acquired

Acquired

Acq - Fin

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

6

1

13

10

10

Jump Capital Fund History

5 Fund Histories

Jump Capital has 5 funds, including JCDP - 7.

Closing Date

Fund

Fund Type

Status

Amount

Sources

9/14/2021

JCDP - 7

$350M

1

12/4/2017

JCDP-5

Subscribe to see more

Subscribe to see more

$99M

10

2/5/2016

JCDP-4

Subscribe to see more

Subscribe to see more

$99M

10

JCDP-6 QP

Subscribe to see more

Subscribe to see more

$99M

10

JCDP-6 AI

$99M

10

Closing Date

9/14/2021

12/4/2017

2/5/2016

Fund

JCDP - 7

JCDP-5

JCDP-4

JCDP-6 QP

JCDP-6 AI

Fund Type

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$350M

$99M

$99M

$99M

$99M

Sources

1

10

10

10

10

Jump Capital Service Providers

1 Service Provider

Jump Capital has 1 service provider relationship

Service Provider

Associated Rounds

Provider Type

Service Type

Counsel

General Counsel

Service Provider

Associated Rounds

Provider Type

Counsel

Service Type

General Counsel

Partnership data by VentureSource

Jump Capital Team

3 Team Members

Jump Capital has 3 team members, including , .

Name

Work History

Title

Status

Sach Chitnis

Founder

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Sach Chitnis

Subscribe to see more

Subscribe to see more

Work History

Title

Founder

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.